468 related articles for article (PubMed ID: 34065871)
1. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.
Drancourt M; Cortaredona S; Melenotte C; Amrane S; Eldin C; La Scola B; Parola P; Million M; Lagier JC; Raoult D; Colson P
Viruses; 2021 May; 13(5):. PubMed ID: 34065871
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
5. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
Gautret P; Lagier JC; Parola P; Hoang VT; Meddeb L; Sevestre J; Mailhe M; Doudier B; Aubry C; Amrane S; Seng P; Hocquart M; Eldin C; Finance J; Vieira VE; Tissot-Dupont HT; Honoré S; Stein A; Million M; Colson P; La Scola B; Veit V; Jacquier A; Deharo JC; Drancourt M; Fournier PE; Rolain JM; Brouqui P; Raoult D
Travel Med Infect Dis; 2020; 34():101663. PubMed ID: 32289548
[TBL] [Abstract][Full Text] [Related]
6. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.
Cochin M; Touret F; Driouich JS; Moureau G; Petit PR; Laprie C; Solas C; de Lamballerie X; Nougairède A
Antiviral Res; 2022 Jan; 197():105212. PubMed ID: 34838583
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates.
Boschi C; Bideau ML; Andreani J; Aherfi S; Jardot P; Delerce J; Gendrot M; Pradines B; Colson P; Levasseur A; La Scola B
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1493-1502. PubMed ID: 34994164
[TBL] [Abstract][Full Text] [Related]
9. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
10. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
Fantini J; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32862840
[TBL] [Abstract][Full Text] [Related]
13. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
[TBL] [Abstract][Full Text] [Related]
14. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU.
Çalık Başaran N; Uyaroğlu OA; Telli Dizman G; Özışık L; Şahin TK; Taş Z; İnkaya AÇ; Karahan S; Alp Ş; Alp A; Metan G; Zarakol P; Sain Güven G; Öz ŞG; Topeli A; Uzun Ö; Akova M; Ünal S
Turk J Med Sci; 2021 Apr; 51(2):411-420. PubMed ID: 32718127
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
Corsini Campioli C; Cano Cevallos E; Assi M; Patel R; Binnicker MJ; O'Horo JC
J Clin Virol; 2020 Sep; 130():104577. PubMed ID: 32777762
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
Dubernet A; Larsen K; Masse L; Allyn J; Foch E; Bruneau L; Maillot A; Lagrange-Xelot M; Thomas V; Jaffar-Bandjee MC; Gauzere L; Raffray L; Borsu K; Dibernardo S; Renaud S; André M; Moreau D; Jabot J; Coolen-Allou N; Allou N
J Glob Antimicrob Resist; 2020 Dec; 23():1-3. PubMed ID: 32828896
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
Kalligeros M; Shehadeh F; Atalla E; Mylona EK; Aung S; Pandita A; Larkin J; Sanchez M; Touzard-Romo F; Brotherton A; Shah R; Cunha CB; Mylonakis E
J Glob Antimicrob Resist; 2020 Sep; 22():842-844. PubMed ID: 32763357
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
